ArticleThe Journal of urology2020

Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine plus Cisplatin in Patients with Muscle-Invasive Bladder Cancer.

Sam S ChangPubMed ↗Publisher ↗

No numbers read from the abstract.